Shares of Lantheus Holdings Inc. (NASDAQ:LNTH) fell 4.9% during mid-day trading on Thursday . The stock traded as low as $4.41 and last traded at $4.50, with a volume of 111,409 shares changing hands. The stock had previously closed at $4.73.

A number of equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Lantheus Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday. Jefferies Group restated a “buy” rating on shares of Lantheus Holdings in a research report on Wednesday, May 4th. Finally, Robert W. Baird restated a “hold” rating on shares of Lantheus Holdings in a research report on Monday, April 11th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $5.55.

The stock’s market cap is $143.33 million. The firm’s 50-day moving average is $2.77 and its 200-day moving average is $2.38.

Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.28. The firm had revenue of $76.50 million for the quarter, compared to analysts’ expectations of $72.43 million. Equities research analysts predict that Lantheus Holdings Inc. will post $0.35 earnings per share for the current fiscal year.

An institutional investor recently raised its position in Lantheus Holdings stock. Numeric Investors LLC boosted its position in Lantheus Holdings Inc. (NASDAQ:LNTH) by 42.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 525,258 shares of the company’s stock after buying an additional 156,084 shares during the period. Numeric Investors LLC owned approximately 1.67% of Lantheus Holdings worth $1,775,000 as of its most recent filing with the SEC.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.